ABSTRACT Introduction Sacral Neuromodulation (SNM) is a minimally invasive treatment
for OAB patients following failure of conventional interventions. Patient selection, lead …

Introduction: Sacral neuromodulation (SNM) is an effective treatment in patients with
overactive bladder syndrome or nonobstructive urinary retention when conservative …

Background: Overactive bladder (OAB) syndrome affects 10–15% of women, severely
impacting their quality of life. First-line treatments include behavioural and physical therapy …

Introduction Overactive bladder (OAB) disproportionally affects older adults in both
incidence and severity. OAB pharmacotherapy is often problematic in the elderly due to …

Purpose This study aimed to seek predictive factors and develop a predictive tool for sacral
nerve modulation (SNM) implantation in patients with non-obstructive urinary retention …

Objectives The aim of this study is to provide a comprehensive evidence-based summary of
the 2021 State-of-the-Science (SOS) conference and a multidisciplinary expert literature …

INTRODUCTION Despite high prevalence and increased severity and burden of overactive
bladder (OAB) and fecal incontinence (FI) in the elderly, sacral neuromodulation (SNM) is …

Objectives This study aimed to report sacral neuromodulation (SNM) outcomes in detrusor
underactivity (DU). Methods A multicentric, multinational, retrospective case series was …

Botulinum toxin A (Botox) had been considered a promising drug that has an effect on
functional disorders of the lower urinary tract. Because Botox exhibits anti-inflammatory and …

Objectives To evaluate if age and medical comorbidities are associated with progression to
implantation of sacral neuromodulation devices in women with symptomatic chronic urinary …